Cyril Llamoso

Cyril Llamoso, MD, currently serves as a Distinguished Scientist at Merck since September 2023. Previously, Cyril held the position of VP- Infectious Disease Clinical Development at Pfizer from October 2022 to September 2023 and was the VP and Head of Infectious Disease Clinical Development at Biohaven Pharmaceuticals from April 2021 to December 2022. Earlier roles include Medicine Development Leader at ViiV Healthcare (February 2016 - April 2021), Group Director of Global Clinical Research - Virology at Bristol-Myers Squibb (June 2006 - February 2016), Assistant Professor in the Department of Medicine (Infectious Diseases) at SUNY Downstate Medical Center (January 2004 - June 2006), and Medical Director at Milwaukee Health Services, Inc. (September 2000 - December 2003). Cyril's educational background includes a Doctor of Medicine (MD) from Southwestern University- MHAM College of Medicine and a B.S. in Medical Technology from Southwestern University, along with additional studies at Makati Medical Center, the Medical College of Wisconsin, and the University of Illinois Chicago.